T2DM
Conditions
Interventions
Aerobic Walking Control Group:Regular walking twice daily at moderate pace reaching 60% of maximum heart rate for 30 minutes per session
Health Education Control Group:Received health education lectures and diabetes nutrition guidance maintaining original lifestyle without exercise intervention.
Fitness Qigong Walking Exercise Treatment Group:Practiced Fitness Qigong Walking Exercise (Invigorating the Spleen and Resolving Turbidity Prescription) twice daily (morning and evening) 30 minutes pe
Sponsors
Nanjing Jiangning Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for type 2 diabetes mellitus; (2) No other serious disorders such as cardiovascular hepatic renal diseases and hematopoietic system; (3) HbA1c basal value of 6.6%-6.9% in the last 6 months; (4) Patients aged 40-75 years with certain reading ability and mobility informed consent and voluntary participation in the study; (5) Patients using biguanide hypoglycemic drugs. Translated with DeepL.com (free version)
Exclusion criteria
Exclusion criteria: (1) Those with abnormal blood glucose caused by other major chronic diseases (e.g. chronic kidney disease systemic lupus erythematosus hypothyroidism etc.); (2)Systolic blood pressure >200mmHg or diastolic blood pressure >110mmHg in quiet state; (3) Those with recent frequent hypoglycemic time (5% in the 2 months before the experiment; (5) Those with a history of critical illnesses such as cerebrovascular accident malignant hypertension myocardial infarction heart failure diabetic ketoacidosis etc. in the last 6 months; (6) Those who are unsuitable for the intervention of this program such as cancer acute infection mental illness and severe motor system abnormalities; (7) Patients with severe musculoskeletal system pathology or with contraindications to exercise; (8) Those with congenital motor dysfunction or those with fractures and trauma in the last year that affect motor function; (9) Those who have changed the type and dosage of medication in the month before the experiment including hypoglycemic antihypertensive and lipid-lowering drugs; (10) Other metabolic abnormalities such as acute thyroiditis hypokalemia hyperkalemia or hypovolemia; (11) Participants in other ongoing clinical trials. Anyone who met any 1 of the above was excluded. Translated with DeepL.com (free version)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Syndrome Score;Low-Density Lipoprotein LDL;Glycosylated Hemoglobin HbA1c;Self-Rating Anxiety Scale Score, SAS;Total Cholesterol, TCH;Triglyceride, TG;Postprandial Blood Glucose PBG;Fasting Blood Glucose FBG;High-Density Lipoprotein, HDL; | — |
Countries
China
Contacts
Public Contactwuyunchuan
Nanjing University of Chinese Medicine
Outcome results
None listed